Skip to main content

Table 1 Survey for symmetrical peripheral gangrene

From: Successful resolution of symmetrical peripheral gangrene after severe acute pancreatitis: a case report

Laboratory test (normal values)

Laboratory value

HBsAg

Nonreactive

HCV antibody

Nonreactive

Cryoglobulin

Negative

ESR, mm/h (0–15)

69mm/h

RPR/VDRL test

Negative

Cold agglutinin antibodies (<1:16×(−); 1:16X(+))

<1:16

C3, mg/dl (86–160)

143

C4, mg/dl (17–45)

30

Protein C, % (70–140%)

78.7

Anti-thrombin III, % (75–125%)

73.4

c-ANCA, IU/ml (<2)

0.1

ANA (<1:20)

<1:20

Anti-DNA, <Day 12 after admission10(−); 10–15(+/−); >15(+)

0.1(−)

Anti-cardiolipin IgM, MPL U/ml (<10)

0.1

Anti-cardiolipin IgG, IU/ml (<10)

0.2

DIC profile

 Platelets (150,000–400,000/μl)

170,000/μl

 PT, s (8.0–12.0)

12.5

 INR

1.27

 aPTT, s (24.3–32.7)

33.1

 D-dimer, ng/ml (<500)

4441.30

 Fibrinogen, mg/dl (150–350)

559.5

 CEA, ng/ml (0–5)

3.77

 AFP, ng/ml (1.09–8.04)

3.20

 CA 19-9, U/ml (0–37)

6.52

 PSA, ng/ml (0–4)

0.622

  1. AFP, α-fetoprotein; ANA, anti-nuclear antibodies; c-ANCA, cytoplasmic anti-neutrophil cytoplasmic antibodies; aPTT, activated partial thromboplastin time; C3, complement component 3; C4, complement component 4; CA 19-9, carbohydrate antigen 19-9; c-ANCA, cytoplasmic anti-neutrophil cytoplasmic antibodies; CEA, carcinoembryonic antigen; DIC, Disseminated intravascular coagulation; ESR, erythrocyte sedimentation rate; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; Ig, immunoglobulin; INR, international normalized ratio; PSA, prostate-specific antigen; PT, prothrombin time; RPR/VDRL, rapid plasma regain/venereal disease research laboratory